BAR HARBOR, MAINE – The MDI Biological Laboratory is launching a new five-day workshop from June 16 to 20 to give students and scientists an understanding of entrepreneurship and the role they can play in bringing new, life-saving drugs and devices to market. Undergraduate interns and faculty members will gain a working knowledge of the process by which biomedical problems are identified and moved through the research stage to the development of a new medical product.
“The MDI Biological Laboratory believes the goal of biological research is to improve human health and well-being,” says Director Kevin Strange. “This workshop will enable our students to envision themselves as part of the critical process of moving discoveries from the laboratory into new therapies. It will help our scientists ensure that their research makes a difference.”
The workshop will be taught by David Huizenga, J.D., Ph.D., president and chief technology officer of TAO Life Sciences and managing director of Upstream Partners. Huizenga has more than fifteen years experience working with early stage technologies at numerous universities and is an expert in translating groundbreaking science into realistic commercial opportunities.
Topics covered will include the ins and outs of the patent system and funding life science discovery and development. A concluding panel discussion will feature three successful life-science entrepreneurs:
- Burt Adelman, M.D., executive vice president for research and development at Dyax Corporation, who has experience in drug development reaching from discovery to development to commercial promotion
- Denise Barbut, M.D., M.R.C.P., founder of six biotech companies and author on nearly 300 medical patents
- Henry Sharpe, product designer, engineer, and entrepreneur, with experience developing, launching, and licensing new products and technology in fields as diverse as oceanography, medical instrumentation, bio-tech, and toys.
The course will take place on Monday though Thursday, June 16 to 10 from 11 am to 1 pm. and 7 to 8 pm. The panel discussion is scheduled for Friday, June 20, from 10:30 am to 12:00 noon.